XML 111 R82.htm IDEA: XBRL DOCUMENT v3.20.4
Restatement for Correction of an Error (Tables) (FaceBank Group, Inc. Pre-Merger)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
FaceBank Group, Inc Pre-Merger [Member]    
Schedule of Restatement of Consolidated Balance Sheets and Operations

Restated consolidated balance sheets and consolidated statements of operations as of and for the three months ended March 31, 2020 are as follows:

 

    March 31, 2020 (unaudited)
as Previously Reported
   

Effect of

Restatement (unaudited)

    March 31, 2020 (unaudited)
as Restated
 
ASSETS                        
Total current assets     10,211       -       10,211  
                      -  
Deposits     24       -       24  
Investment in Nexway at fair value     2,374       -       2,374  
Financial assets at fair value     1,965       -       1,965  
Intangible assets     111,459       -       111,459  
Goodwill     148,054       28,541       176,595  
Right-of-use assets     37       -       37  
Total assets   $ 274,124     $ 28,541     $ 302,665  
                      -  
LIABILITIES AND STOCKHOLDERS’ EQUITY                     -  
Total current liabilities     41,601       -       41,601  
Total liabilities     125,411       -       125,411  
                      -  
COMMITMENTS AND CONTINGENCIES (Note 15)                     -  
                      -  
Series D Convertible Preferred stock, par value $0.0001, 2,000,000 shares authorized, 461,839 shares issued and outstanding as of March 31, 2020; aggregate liquidation preference of $463 as of March 31, 2020     463       -       463  
                      -  
Stockholders’ equity:                     -  
Common stock par value $0.0001: 400,000,000 shares authorized; 32,307,663 shares issued and outstanding at March 31, 2020     3       -       3  
Additional paid-in capital     270,397       -       270,397  
Accumulated deficit     (140,134 )     28,541       (111,593 )
Non-controlling interest     17,984       -       17,984  
Total stockholders’ equity     148,250       28,541       176,791  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY AND TEMPORARY EQUITY   $ 274,124     $ 28,541     $ 302,665  

 

    For the Three Months Ended March 31, 2020
as Previously Reported (unaudited)
    Effect of
Restatement (unaudited)
    For the Three Months Ended
March 31, 2020
as Restated (unaudited)
 
Operating loss     (18,128 )     -       (18,128 )
                      -  
Other income (expense)                     -  
Interest expense and financing costs     (2,581 )     -       (2,581 )
Gain (loss) on deconsolidation of Neway     39,249       (51,168 )     (11,919 )
Loss of issuance of notes, bonds & warrants     (24,053 )     -       (24,053 )
Other expense     (436 )     -       (436 )
Change in fair value of warrant liability     (366 )     -       (366 )
Change in fair value of subsidiary warrant liability     (15 )     -       (15 )
Change in fair value of shares settled liability     (180 )     -       (180 )
Change in fair value of derivative liability     297       -       297  
Total other income (expense)     11,915       (51,168 )     (39,253 )
Loss before income taxes     (6,213 )     (51,168 )     (57,381 )
Income tax benefit     (1,038 )     -       (1,038 )
Net loss     (5,175 )     (51,168 )     (56,343 )
Less: net loss attributable to non-controlling interest     873       -       873  
Net loss attributable to controlling interest   $ (4,302 )   $ (51,168)     $ (55,470 )
Less: Deemed dividend - beneficial conversion feature on preferred stock     (171 )     -       (171 )
Net loss attributable to common stockholders   $ (4,473 )   $ (51,168)     $ (55,641 )
                         
Net loss per share attributable to common stockholders                        
Basic and diluted   $ (0.15 )           $ (1.83 )
                         
Weighted average shares outstanding:                        
Basic and diluted     30,338,073       -       30,338,073  

Restated consolidated balance sheets and consolidated statements of operations as of and for the year ended December 31, 2019 are as follows:

 

    December 31, 2019
as Previously Reported
   

Effect of

Restatement

    December 31, 2019
as Restated
 
ASSETS                        
Current assets                        
Cash   $ 7,624     $ -     $ 7,624  
Accounts receivable, net     8,904       -       8,904  
Inventory     49       -       49  
Prepaid expenses     1,396       -       1,396  
Total current assets     17,973       -       17,973  
                      -  
Property and equipment, net     335       -       335  
Deposits     24       -       24  
Financial assets at fair value     1,965       -       1,965  
Intangible assets     116,646       -       116,646  
Goodwill     148,054       79,709       227,763  
Right-of-use assets     3,519       -       3,519  
Total assets   $ 288,516     $ 79,709     $ 368,225  
                      -  
LIABILITIES AND STOCKHOLDERS’ EQUITY                     -  
Current liabilities                     -  
Accounts payable     36,373       -       36,373  
Accrued expenses     20,402       -       20,402  
Due to related parties     665       -       665  
Note payable     4,090       -       4,090  
Notes payable - related parties     368       -       368  
Convertible notes, net of $710 and $456 discount as of December 31, 2019 and 2018, respectively     1,358       -       1,358  
Convertible notes - related parties     -       -       -  
Shares settled liability for intangible asset     1,000       -       1,000  
Profit share liability     1,971       -       1,971  
Warrant liability - subsidiary     24       -       24  
Derivative liability     376       -       376  
Current portion of lease liability     815       -       815  
Total current liabilities     67,442       -       67,442  
                      -  
Deferred income taxes     30,879       -       30,879  
Other long-term liabilities     41       -       41  
Lease liability     2,705       -       2,705  
Long term borrowings     43,982       -       43,982  
Total liabilities     145,049       -       145,049  
                      -  
COMMITMENTS AND CONTINGENCIES (Note 15)                     -  
                      -  
Series D Convertible Preferred stock, par value $0.0001, 2,000,000 shares authorized, 461,839 shares issued and outstanding as of December 31, 2019; aggregate liquidation preference of $462 as of December 31, 2019     462       -       462  
                      -  
Stockholders’ equity:                     -  
Series A Preferred stock, par value $0.0001, 5,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2019 and 2018, respectively     -       -       -  
Series B Convertible Preferred stock, par value $0.0001, 1,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2019 and 2018, respectively     -       -       -  
Series C Convertible Preferred stock, par value $0.0001, 41,000,000 shares authorized, 0 shares issued and outstanding as of December 31, 2019 and 2018, respectively     -       -       -  
Series X Convertible Preferred stock, par value $0.0001, 1,000,000 shares authorized, 0 and 1,000,000 shares issued and outstanding as of December 31, 2019 and 2018, respectively     -       -       -  
Common stock par value $0.0001: 400,000,000 shares authorized; 28,912,500 shares issued and 7,532,776 shares outstanding at December 31, 2019 and 2018, respectively     3       -       3  
Additional paid-in capital     257,002       -       257,002  
Accumulated deficit     (135,832 )     79,709       (56,123 )
Non-controlling interest     22,602       -       22,602  
Accumulated other comprehensive loss     (770 )     -       (770 )
Total stockholders’ equity     143,005       79,709       222,714  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY AND TEMPORARY EQUITY   $ 288,516     $ 79,709     $ 368,225  

 

    For the Year Ended December 31, 2019
as Previously Reported
    Effect of
Restatement
    For the Year Ended
December 31, 2019
as Restated
 
Revenues                        
Revenues, net   $ 4,271     $ -     $ 4,271  
Total revenues     4,271       -       4,271  
Operating expenses                     -  
General and administrative     13,793       -       13,793  
Amortization of intangible assets     20,682       -       20,682  
Impairment of intangible assets     8,598       -       8,598  
Impairment of goodwill     74,441       (74,441 )     -  
Depreciation     83       -       83  
Total operating expenses     117,597       (74,441 )     43,156  
Operating loss     (113,326 )     74,441       (38,885 )
                      -  
Other income (expense)                     -  
Interest expense and financing costs     (2,062 )     -       (2,062 )
Gain on extinguishment of convertible notes     -       -       -  
Loss on investments     (13,549 )     5,268       (8,281 )
Foreign currency loss     (18 )     -       (18 )
Other expense     726       -       726  
Change in fair value of subsidiary warrant liability     4,504       -       4,504  
Change in fair value of derivative liability     815       -       815  
Change in fair value of Panda interests     (198 )     -       (198 )
Total other income (expense)     (9,782 )     5,268       (4,514 )
Loss before income taxes     (123,108 )     79,709       (43,399 )
Income tax benefit     (5,272 )     -       (5,272 )
Net loss     (117,836 )     79,709       (38,127 )
Less: net loss attributable to non-controlling interest     3,767       -       3,767  
Net loss attributable to controlling interest   $ (114,069 )   $ 79,709     $ (34,360 )
Less: Deemed dividend on Series D Preferred stock     (9 )     -       (9 )
Less: Deemed dividend - beneficial conversion feature on preferred stock     (589 )     -       (589 )
Net loss attributable to common stockholders   $ (114,667 )   $ 79,709     $ (34,958 )
                         
Other comprehensive income (loss)                        
Foreign currency translation adjustment     (770 )     -       (770
Comprehensive loss   $ (115,437 )   $ 79,709     $ (35,728 )
                         
Net loss per share attributable to common stockholders                        
Basic and diluted   $ (5.15 )           $ (1.57 )
                         
Weighted average shares outstanding:                        
Basic and diluted     22,286,060       -       22,286,060